113 related articles for article (PubMed ID: 30267584)
1. Shenmai injection improves the postoperative immune function of papillary thyroid carcinoma patients by inhibiting differentiation into Treg cells via miR-103/GPER1 axis.
Fang T; Li J; Wu X
Drug Dev Res; 2018 Nov; 79(7):324-331. PubMed ID: 30267584
[TBL] [Abstract][Full Text] [Related]
2. High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma.
Tang C; Yang L; Wang N; Li L; Xu M; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2014; 7(6):3213-23. PubMed ID: 25031742
[TBL] [Abstract][Full Text] [Related]
3. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
[TBL] [Abstract][Full Text] [Related]
4. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Liu Y; Yun X; Gao M; Yu Y; Li X
Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO.
Pei X; Wang X; Li H
Int J Biol Macromol; 2018 Oct; 118(Pt A):24-30. PubMed ID: 29886172
[TBL] [Abstract][Full Text] [Related]
6. MiR-133a/133b inhibits Treg differentiation in IgA nephropathy through targeting FOXP3.
Jin LW; Ye HY; Xu XY; Zheng Y; Chen Y
Biomed Pharmacother; 2018 May; 101():195-200. PubMed ID: 29494956
[TBL] [Abstract][Full Text] [Related]
7. Zhenbao Pill reduces Treg cell proportion in acute spinal cord injury rats by regulating TUG1/
He Y; Li M; Wujisiguleng ; Lv B; Huan Y; Liu B; Wang D; Yu H; Zhang L; Shi Z
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30287503
[No Abstract] [Full Text] [Related]
8. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2.
Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV attenuates inflammatory reaction via activating immune function of regulatory T-cells inhibited by HMGB1 in mice.
Li J; Huang L; Wang S; Yao Y; Zhang Z
Pharm Biol; 2016 Dec; 54(12):3217-3225. PubMed ID: 27564970
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy suppressed tumor-specific recruitment of regulator T cells via up-regulating microR-545 in Lewis lung carcinoma cells.
Liao C; Xiao W; Zhu N; Liu Z; Yang J; Wang Y; Hong M
Int J Clin Exp Pathol; 2015; 8(3):2535-44. PubMed ID: 26045759
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
[TBL] [Abstract][Full Text] [Related]
13. MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.
Wang XY; Chen XY; Li J; Zhang HY; Liu J; Sun LD
Biomed Pharmacother; 2017 Sep; 93():1158-1164. PubMed ID: 28738533
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-791 is an independent prognostic factor of papillary thyroid carcinoma and inhibits the proliferation of PTC cells.
Gao XB; Chen CL; Tian ZL; Yuan FK; Jia GL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5562-5568. PubMed ID: 30229829
[TBL] [Abstract][Full Text] [Related]
15. Role of MicroRNA 146a in Regulating Regulatory T Cell Function to Ameliorate Acute Cardiac Rejection in Mice.
Wang X; Cao J; Yu Y; Ma B; Gao C; Lu J; Lin Y; Li P; Qi F
Transplant Proc; 2019 Apr; 51(3):901-912. PubMed ID: 30979483
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of microRNA in CD4
Hua M; Li J; Wang C; Shao L; Hou M; Peng J; Feng Q
Thromb Res; 2019 May; 177():70-78. PubMed ID: 30856381
[TBL] [Abstract][Full Text] [Related]
18. Alpinetin exerts anti-colitis efficacy by activating AhR, regulating miR-302/DNMT-1/CREB signals, and therefore promoting Treg differentiation.
Lv Q; Shi C; Qiao S; Cao N; Guan C; Dai Y; Wei Z
Cell Death Dis; 2018 Aug; 9(9):890. PubMed ID: 30166541
[TBL] [Abstract][Full Text] [Related]
19. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer.
Sun W; Lan X; Zhang H; Wang Z; Dong W; He L; Zhang T; Zhang P; Liu J; Qin Y
Cell Death Dis; 2018 Mar; 9(3):380. PubMed ID: 29515109
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
